![](/img/cover-not-exists.png)
GRK2 is a novel early marker of cardiotoxicity in response to doxorubicin
Gambardella, J., Fiordelisi, A., De Rosa, M., Ciccarelli, M., Trimarco, B., Iaccarino, G., Sorriento, D.Volume:
120
Language:
english
Journal:
Journal of Molecular and Cellular Cardiology
DOI:
10.1016/j.yjmcc.2018.05.103
Date:
July, 2018
File:
PDF, 49 KB
english, 2018